NCT00040274View on ClinicalTrials.gov

A Study of DPC 817 in HIV-Infected Males

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

DPC 817

Trial Locations (2)

27514

University of North Carolina Hospitals, Chapel Hill

Unknown

3ClincalResearch Center, Berlin

Sponsors

Lead Sponsor

Pharmasset
All Listed Sponsors
lead

Pharmasset

INDUSTRY

NCT00040274 - A Study of DPC 817 in HIV-Infected Males | Biotech Hunter | Biotech Hunter